Lihit Lab.,Inc. (TYO:7975)
1,165.00
-7.00 (-0.60%)
Apr 17, 2026, 2:11 PM JST
Lihit Lab.,Inc. Balance Sheet
Financials in millions JPY. Fiscal year is March - February.
Millions JPY. Fiscal year is Mar - Feb.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Feb '25 Feb 28, 2025 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 |
Cash & Equivalents | 728 | 2,332 | 1,242 | 1,077 | 2,259 |
Cash & Short-Term Investments | 728 | 2,332 | 1,242 | 1,077 | 2,259 |
Cash Growth | -68.78% | 87.76% | 15.32% | -52.32% | 25.71% |
Receivables | 2,071 | 1,829 | 1,729 | 1,766 | 1,651 |
Inventory | 2,708 | 2,870 | 2,554 | 2,839 | 2,513 |
Other Current Assets | 217 | 174 | 221 | 343 | 126 |
Total Current Assets | 5,724 | 7,205 | 5,746 | 6,025 | 6,549 |
Property, Plant & Equipment | 5,805 | 4,658 | 5,810 | 5,207 | 5,359 |
Long-Term Investments | 1,928 | 1,504 | 1,505 | 1,483 | 1,401 |
Other Intangible Assets | 42 | 43 | 40 | 16 | 18 |
Long-Term Deferred Tax Assets | 15 | 20 | 15 | - | - |
Other Long-Term Assets | 2 | 2 | 1 | 1 | 2 |
Total Assets | 13,516 | 13,432 | 13,117 | 12,732 | 13,329 |
Accounts Payable | 329 | 315 | 192 | 185 | 481 |
Accrued Expenses | 189 | 175 | 159 | 150 | 118 |
Short-Term Debt | - | - | - | 130 | 253 |
Current Portion of Long-Term Debt | 112 | 242 | 314 | - | - |
Current Income Taxes Payable | 18 | 143 | 36 | 13 | 107 |
Other Current Liabilities | 405 | 427 | 379 | 307 | 352 |
Total Current Liabilities | 1,053 | 1,302 | 1,080 | 785 | 1,311 |
Long-Term Debt | 170 | 195 | 437 | 315 | 445 |
Pension & Post-Retirement Benefits | 696 | 841 | 842 | 904 | 961 |
Long-Term Deferred Tax Liabilities | 403 | 214 | 241 | 224 | 210 |
Other Long-Term Liabilities | 216 | 244 | 276 | 285 | 293 |
Total Liabilities | 2,538 | 2,796 | 2,876 | 2,513 | 3,220 |
Common Stock | 1,830 | 1,830 | 1,830 | 1,830 | 1,830 |
Additional Paid-In Capital | 1,411 | 1,411 | 1,411 | 1,411 | 1,411 |
Retained Earnings | 6,651 | 6,669 | 6,342 | 6,521 | 6,624 |
Treasury Stock | -401 | -401 | -401 | -401 | -401 |
Comprehensive Income & Other | 1,487 | 1,127 | 1,059 | 858 | 645 |
Shareholders' Equity | 10,978 | 10,636 | 10,241 | 10,219 | 10,109 |
Total Liabilities & Equity | 13,516 | 13,432 | 13,117 | 12,732 | 13,329 |
Total Debt | 282 | 437 | 751 | 445 | 698 |
Net Cash (Debt) | 446 | 1,895 | 491 | 632 | 1,561 |
Net Cash Growth | -76.46% | 285.95% | -22.31% | -59.51% | 49.23% |
Net Cash Per Share | 131.45 | 558.50 | 144.71 | 186.27 | 460.06 |
Filing Date Shares Outstanding | 3.39 | 3.39 | 3.39 | 3.39 | 3.39 |
Total Common Shares Outstanding | 3.39 | 3.39 | 3.39 | 3.39 | 3.39 |
Working Capital | 4,671 | 5,903 | 4,666 | 5,240 | 5,238 |
Book Value Per Share | 3235.51 | 3134.70 | 3018.26 | 3011.51 | 2979.02 |
Tangible Book Value | 10,936 | 10,593 | 10,201 | 10,203 | 10,091 |
Tangible Book Value Per Share | 3223.13 | 3122.03 | 3006.48 | 3006.80 | 2973.71 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.